A Phase 2 Trial to Evaluate Safety and Efficacy of Treatment of Physician Choice (TPC) Following First Line Treatment in Pateints with Unresectable Hepatocellular Carcinoma (HCC)

August 07, 2018
https://clinicaltrials.gov/ct2/show/NCT03433703
Gastroenterology Hepatology
Principal Investigator: Reena J Salgia, MD
liver cancer, hepatocellular carcinoma, unresectable, hcc, HCC
Open